Biofarm S.A., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and has established a significant presence across various operational regions. Founded in 1991, the company has achieved notable milestones, including the expansion of its product portfolio and the enhancement of its manufacturing capabilities. Specialising in the development and production of high-quality generic medicines, Biofarm S.A. is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of pharmaceuticals, particularly in the fields of cardiology, dermatology, and gynaecology, setting it apart with its rigorous adherence to international standards. With a strong market position, Biofarm S.A. has garnered numerous accolades for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
Biofarm S.A., headquartered in Romania, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Biofarm S.A. may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, where sustainability and climate action are increasingly critical, Biofarm S.A. may need to consider developing a comprehensive strategy to address carbon emissions and set measurable reduction targets. This could enhance their environmental responsibility and align with global climate goals.
Access structured emission data, company specific emission factors, and source documents.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biofarm S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.



You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Book a demo for your project.